DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Jb Reed - 1 It's - 1 Erin Fox - 1 they've - 1 David Margraf - 1 Margraf - 1 drugmakers - 1 Ozlem Ergun - 1
Top related locs:
U.S Commerce City , Colorado Japan United States
Top related orgs:
Shire Plc - 2 Jb - 1 Bloomberg - 1 Getty - 1 and Drug Administration - 1 CNBC - 1 University of Utah - 1 American Society of Health - 1

Search resuls for: "Shire Plc"


3 mentions found


☆ The ADHD drug market is already stretched thin. Now it's facing a back-to-school supply strain
  + stars: | 2023-08-26 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +8 min
Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire Plc. Adderall and alternative ADHD medications apart from other drugs are Schedule 2 controlled substances. Production limitationsEnding the shortages of Adderall and other ADHD medications is no easy task. That means increasing the production of one drug could potentially require reducing production — and potentially impacting supply — of another drug, according to Ergun. That includes Aytu BioPharma, which makes an ADHD drug that used to be in shortage.
Persons: Jb Reed, It's, Erin Fox, they've, David Margraf, Margraf, drugmakers, Ozlem Ergun, Ergun, Novartis's, Michael Ganio, ASHP's Ganio, RJ Sangosti, Josh Disbrow, Fox Organizations: Shire Plc, Jb, Bloomberg, Getty, and Drug Administration, CNBC, University of Utah, American Society of Health, System Pharmacists, Centers for Disease Control, University of Minnesota's, Infectious Disease, Northeastern University, Teva Pharmaceuticals, Amneal Pharmaceuticals, Sandoz, Purdue Pharma, Rhodes Pharmaceuticals, Drug, Fox, Pharmacists, Drug Enforcement Administration, MediaNews, Denver, FDA, DEA Locations: U.S, Commerce City , Colorado
☆ Japan's Takeda beats Q1 profit estimates on mainstay drugs, dengue vaccine
  + stars: | 2023-07-27 | by ( ) www.reuters.com   time to read: +2 min
Companies Takeda Pharmaceutical Co Ltd FollowTOKYO, July 27 (Reuters) - Japan's Takeda Pharmaceutical (4502.T) posted first-quarter profit that beat analysts' estimates, citing solid sales of mainstay drugs and the launch of new products including its dengue fever vaccine. Operating profit rose 12% from a year earlier to 168.6 billion yen ($1.2 billion) in the three months through June 30, the drugmaker said. That compared with an average forecast of 150.7 billion yen from six analysts polled by Refinitiv. The company held its forecast for full-year operating profit at 349 billion yen. Analysts expect 481.1 billion yen on average for the year.
Persons: Takeda, Rocky Swift, Tom Hogue, Robert Birsel Organizations: Takeda Pharmaceutical, Refinitiv, Therapeutics, Shire Plc, Nikkei, Thomson Locations: Japan, United States, U.S
☆ For Takeda Pharmaceutical’s CFO, ‘Speed and Agility’ Were Key to Shire Tie-Up
  + stars: | 2023-03-01 | by ( Anna Mutoh | Costa Saroukos | Cfo Of Takeda | ) www.wsj.com   time to read: +9 min
Takeda CFO Costa Saroukos in a 2018 picture. Mr. Saroukos joined Takeda in 2015 as CFO of Takeda’s European and Canadian operations before he was elevated to global CFO in 2018. WSJ: What did you learn from your deal-integration experiences that helped with the Takeda and Shire integration? ” — Costa Saroukos, CFO of TakedaAnother reason speed is important is to avoid losing talent. We broadened CFOinUrpocket to be used globally across 80 countries for the combined Takeda and Shire offices.
0 next >>
Total: 3